Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,192.36 +11.62 (+0.22%) Dow
38,964.39 +112.12 (+0.29%) Nasdaq
16,359.44 +10.19 (+0.06%) Bitcoin USD
63,512.43 -225.97 (-0.35%) CMC Crypto 200
1,312.73 -52.40 (-3.84%)
IGMS Jun 2024 20.000 call
| Previous close | 2.8200 |
| Open | N/A |
| Bid | 0.0500 |
| Ask | 1.3000 |
| Strike | 20.00 |
| Expiry date | 2024-06-21 |
| Day's range | 2.8200 - 2.8200 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
GlobeNewswireIGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.
ZacksAkoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Akoya (AKYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
